top of page

Search Results

Search this site

66 results found

  • Atopic Dermatitis Targeted Panel | Sequential

    Atopic dermatitis (AD), a chronic inflammatory skin condition, affects around 31.6 million people in the U.S., with 15-20% of children globally and 7.3% of U.S. adults experiencing the condition. TARGETED SKIN PANEL Atopic Dermatitis Targeted Panel 23 Smart Probes ™ Atopic Dermatitis Panel Validated targets: Staphylococcus aureus, Malassezia spp, Staphylococcus epidermidis Absolute Quantification End-to-end Service Qet a Quote Atopic Dermatitis Study with Sequential's Cutting-Edge Microbiome Testing Why Microbiome Testing for Atopic Dermatitis? Atopic dermatitis (AD), a chronic inflammatory skin condition, affects around 31.6 million people in the U.S., with 15-20% of children globally and 7.3% of U.S. adults experiencing the condition (National Eczema Association). AD often results from a combination of genetic predisposition and environmental triggers, such as irritants in cosmetic products. Disruptions to the skin’s microbiome play a significant role in the disease's development and severity. Imbalances in beneficial and harmful microbes can exacerbate AD, highlighting the importance of targeted treatments. In vivo testing for products aimed at managing AD is essential because it allows researchers to understand how formulations impact both the skin barrier and microbiome in real-world conditions. Properly tested products can help reduce irritation and avoid worsening symptoms, offering a science-backed approach to skincare for those with AD. Sequential is leading the way in microbiome testing for the industry. With a specialized focus on skin conditions, we have developed an innovative solution tailored to help you understand the root causes of AD at the microbial level. Our proprietary sequencing panel is designed specifically to offer in-depth analysis of AD-associated microbiota, giving you the tools to transform skincare solutions. Customized Analysis Tailored insights specific to AD-prone skin, allowing your R&D team to develop more personalized and effective products. Actionable Data Leverage detailed reports to guide formulation decisions and validate product efficacy with precision. Product Innovation New AD treatments or enhancing existing lines, our data helps you create targeted solutions with proven results. Precision Sequencing Target specific microbial communities associated with AD development and severity. Smart Probe s ™ Our dedicated team of scientists has developed a revolutionary method for evaluating microbes through our Smart Probes™. This proprietary panel includes 23 key microbes that we have specifically identified as having the most significant impact on skin health. To further understand the intricate relationship between atopic dermatitis (AD) and the skin microbiome, we use qPCR technology. This advanced technique allows us to precisely quantify microbial populations on the skin, providing deeper insights into how AD affects the microbiome. By closely monitoring how products interact with both beneficial and harmful microbes, companies can create solutions for AD but also restore a healthy balance to the skin’s ecosystem. Atopic Dermatitis Panel Targets Staphylococcus aureus This bacterium is frequently found in higher numbers on the skin of individuals with atopic dermatitis. It can exacerbate inflammation and contribute to skin barrier disruption. Malassezia spp This genus of yeast, which is part of the normal skin flora, can become overgrown in individuals with atopic dermatitis, potentially aggravating symptoms. Staphylococcus epidermidis While generally considered a commensal organism, imbalances in its population, along with other microbes, can influence the skin's health and contribute to atopic dermatitis symptoms. Industry Leader in Absolute Quantification Sequential’s Smart Probe ™ qPCR approach to microbiome analysis can resolve species and subspecies, giving statistically significant findings between skin conditions on in vivo human samples, compared to conventional sequencing approaches. Relevant Research Your Skin Barrier Isn't Working Alone Revolutionising Eczema Care: The Promise of Live Biotherapeutic Products AOB for AD: Ammonium-oxidising Bacteria as an Innovative Approach to Managing Atopic Dermatitis Read More Articles

  • Recruitment | Sequential

    Participate in Sequential’s skin, scalp, oral and intimate-care microbiome studies. Join our research community and help brands create evidence-based products. Join Our Research Community At Sequential, we’re advancing the science of personal care by testing products for large, industry formulators to ensure that clinically back solutions are presented to consumers worldwide. To do this, we collaborate with individuals who are interested in contributing to cutting-edge research that helps companies and scientists better understand how the microbiome and human biomarkers can impact the health of skincare, scalp care, intimate care and oral care. Why Participate? By joining our participant community, you will: Contribute to meaningful scientific research that drives innovation in personal care and pharma. Support the development of evidence-based products. Receive clear instructions and research updates tailored to each study you join. Help shape the future of personal care science. Participate In A Study First name* Last name* Email* Write a message I agree to the Privacy Policy and consent to data processing. Submit

  • Sample Microbiome & Gene Expression | Sequential

    Taking a microbiome sample for the purpose of gene expression.

  • Participate In Research | Sequential

    Take part in clinical research. Sign up through DataCap to be matched with Sequential studies that suit your profile, characteristics and location. Participate in Research. Help Shape What’s Next. Join our participant community and be the first to hear about paid clinical research opportunities in skincare, scalp health, oral care, intimate health, and everyday wellness. Join Our Participant Community View Active Studies Choose your location to get started Join Our Participant Community Join in NYC Join in UK Join in Singapore Why Participate Participating in clinical research is an opportunity to contribute to the development of new knowledge while being compensated for the time and commitment involved in eligible studies. Whether you're curious to learn more about research related to skin, scalp, oral or intimate health, interested in contributing to scientific discovery, or simply looking for opportunities that compensate you for your participation, joining our community connects you with studies that may be relevant to you. Up How It Works Joining is simple. Start by creating your participant profile and sharing information that helps us identify research opportunities that may be relevant to you. When a potential study matches your profile, you'll have the opportunity to review key details—including eligibility requirements, location, time commitment, study activities and compensation—before deciding whether you'd like to take the next step. If you're eligible and choose to participate, our research team will guide you through the study process and explain what to expect at each stage. Up Why Trust Sequential At Sequential, trust starts with transparency. Our studies are IRB reviewed and approved and conducted according to Good Clinical Practice (GCP) standards. We prioritize informed consent, clear communication, and responsible handling of participant information, so you understand what to expect, how your information is handled, and what participation involves before you decide to take part. Up IRB APPROVED Our studies undergo independent ethical review to help protect participants’ rights, safety, and well-being. Hear From Our Participants Taylor M. Everything was explained really clearly from the beginning, so I knew exactly what to expect. The team was friendly, professional, and made the whole experience feel easy. Chloe C. I was a little unsure about participating in a study at first, but the team answered all my questions and made me feel comfortable throughout the process. I would definitely participate again. Lisa D. I originally signed up because I was curious about the research, and I ended up really enjoying the experience. Scheduling was straightforward, and I appreciated being compensated for my time. Frequently asked questions Do I get paid for participating in a study? All of our studies offer compensation for your time and participation. Compensation varies depending on the study, including its duration, number of visits, and activities involved. The amount will be clearly communicated before you decide to participate. How much time does a study take? Every study is different. Some may require a single visit, while others involve multiple visits or at-home activities. You’ll receive information about the expected time commitment and schedule before enrolling so you can decide whether it works for you. What happens after I join the participant community? After signing up, the information you provide helps us identify research opportunities that may be relevant to you. When there’s a potential match, we may contact you with more information and invite you to complete a study-specific eligibility screening View all

  • Find Us | Sequential

    Certify your skincare product with us! Maximise microbiome benefits in your strategy. Let's start today for success! Supporting Global Studies Our Labs Sequential has clinical testing labs in New York City, Cambridge, and Singapore. Being close to our customers has allowed us to reduce turnaround time while retaining intellectual property in-house. Cambridge Lab Moneta Building Babraham Research Campus Cambridge CB22 3AT New York Lab Sequential (SOSV) 7 Penn Plaza 9th Fl New York NY 10001 Singapore Lab Astar Central 79 Ayer Rajah Crescent Singapore 139955 Not in your area? No problem. Get in touch with our team Sequential's proprietary technology allows us to conduct fully remote testing wherever you are. Contact us

  • Biome Masks | Sequential

    The Biome Mask has been created with the goal of maintaining the microbiome while targeting concerns such as skin dehydration and sensitivity. Introducing the Biome Mask™ Sequential Skin is proud to announce its biodegradable Biome Mask™ line designed to balance the skin microbiome and make your skin healthier. The Biome Mask™ line has five formulas to target five skin traits. Each is infused with serums that target specific concerns and uses prebiotics and postbiotics to balance the skin's microbiome. All masks have been tested in vivo. Made for all skin types Our formula, your benefits Semi-gel Tencel™ Versatile, soft & pleasant to the skin Eco-friendly Material Better for you and the planet 100% Cellulose Cellulose is the most abundant natural organic compound on Earth Remarkable Moisture Retention For long lasting benefits Click Here to see a Full List of our Ingredients How They Work Prebiotics Prebiotics beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria on the skin, and thus improves host health. Feed your skin microbiome! Prebiotics act as good for the microbes on the skin, and allow good bacteria to grow and thrive. Probiotics Probiotics are living microorganisms that confer benefit to the host when applied to the body. Because probiotics are live bacteria, it is incredibly difficult to preserve and put into skincare products (especially when skincare contains preservatives). In fact, some products on the market that say they use probiotics, are actually using prebiotics or postbiotics. Postbiotics Postbiotics are the byproduct of fermented live bacteria (probiotics) or inactivated microorganisms. The process of fermentation releases nutrients inside of the bacteria and holds concentrated and nourishing skin health benefits that help to balance the skin microbiome. INGREDIENTS FROM MICROBIAL ORIGIN No INTENDED TO BE UTILISED BY THE HUMAN MICROBIOTA? No Yes Yes ARE THEY VIABLE? No Yes ORIGIN VIABILITY FUNCTION ORDINARY INGREDIENT ORDINARY INGREDIENT WITH PREBIOTIC FUNCTION INTENDED TO BE UTILISED BY THE HUMAN MICROBIOTA? PROBIOTIC INGREDIENT No Yes POSTBIOTIC INGREDIENT POSTBIOTIC INGREDIENT WITH PREBIOTIC FUNCTION Also available in a box of 5 Biome Masks™ Interested? Frequently asked questions What is the Biome Mask™ made from? We provide Semi-Gel Tencel masks that are made of 100% cellulose material and are eco-friendly. Each one of our masks is infused with serums that target your specific skin care needs. Semi-gel Tencel masks have the remarkable ability to retain moisture, making them better than cotton sheet masks and feel softer on the skin. What ingredients are used in the Biome Mask™? Each of our sheet masks comes with a fully transparent list of ingredients used in the mask. We do not use any of the following in our sheet masks: irritants, fragrances, essential oils, sulfates, formaldehyde releasers, nanoparticles, ethanolamines, and alcohol. Are the masks biodegradable? Yes, each Biome Mask™ is made of semi-gel Tencel, which is 100% biodegradable. What is the shelf life of the masks? You can find the manufacturing and best before date details printed on the front of the mask sachet. Please note that when the packaging is opened, the Biome Mask™ must be used immediately. What is the purpose of using a sheet mask? When it comes to skincare products, many don’t absorb into the skin, they evaporate, leaving none of the benefits to soak in. With sheet masks, a barrier is formed to lock in the ingredients and promote absorption resulting in plumper feeling skin. How long should the mask be left on the face? Our Biome Mask™ should be left on the skin for 15-20 minutes. Once you remove the mask, you can massage the excess formula into your skin for maximum benefit.

  • Dermocosmetics & Personal Care Testing | Sequential

    Build clinical-grade evidence for dermocosmetic and personal care products, from actives to finished formulas, with human and microbiome biomarkers. SKIN SCALP ORAL INTIMATE SUPPLEMENTS Advanced claims, backed by biology. We help innovative dermocosmetic and personal care brands generate clinical-grade evidence and multi-omics insight, revealing not just efficacy, but true mechanisms of action and competitive positioning. Prove your product’s impact How do you stand out The era of generic claims is ending. “Clinically tested.” These claims are everywhere and increasingly meaningless. Today’s consumers, regulators, and partners expect more than surface-level validation. They want to understand how a product works, not just what it claims to do. For truly innovative brands, this creates a challenge: How do you stand out when weak claims are easy, and real science is hard to communicate? Beyond validation Beyond validation, into biological understanding Sequential combines clinical testing with multi-omics and molecular analysis to uncover how products interact with human biology. We don’t just tell you if your product works. We show you: What biological systems it impacts Clinical-grade evidence demonstrating real biological impact. Credible scientific proof Mechanism of action clarity Translate molecular data into a defensible scientific claim and story. Competitive positioning Understand how your product differentiates and competes within its category. Our process is designed to turn data into clear, defensible claims. We work closely with each client to design tailored clinical studies, recruit relevant participants, and collect high-quality samples using non-invasive methods. Through multi-omics analysis and in-house expertise, we generate a comprehensive understanding of product impact, translating complex biological data into scientifically grounded, claim-ready insights that drive confidence and growth. Start your validation study How it works

  • Sequential & Genom Partnership | Sequential

    Genom and Sequential Announce Strategic Partnership to Advance Microbiome Testing Services in Personal Care and Pharma Sectors Zagreb, Croatia / London, UK – May 6 2025 – Genom d.o.o., a Croatian-based provider of genetic testing services, and Sequential Skin Ltd, a UK-based leader in end-to-end microbiome testing solutions, are pleased to announce a strategic partnership aimed at expanding access to advanced microbiome testing across the personal care and pharmaceutical industries. Through this agreement, Genom and Sequential are collaborating to expand microbiome testing efforts across the Balkans and Slavic regions—areas that have historically been underrepresented in microbiome research. By combining Genom’s deep regional expertise and network with Sequential’s advanced testing platform, the partnership aims to unlock valuable insights from a more diverse population base. This initiative supports both companies’ shared vision of advancing personalized health and product development through inclusive, data-driven innovation in the personal care and pharmaceutical industries. Sequential’s proprietary platform offers extensive sampling capabilities—including skin, scalp, oral, gut, and intimate areas—combined with advanced downstream analysis techniques such as qPCR and next-generation sequencing. With over a decade of academic research backing its methodology, Sequential empowers brands to better understand individual microbiomes and tailor products accordingly. Genom brings to the partnership a strong foundation in molecular biology and over a decade of experience in genetic testing, now expanding into microbiome analytics to support local companies in developing evidence-based products in the personal care and pharmaceutical sectors. Together with Sequential, Genom will play a key role in supporting regional operations, and scientific collaboration. This partnership is designed to jointly deliver tailored microbiome solutions to personal care and pharmaceutical companies. “Partnering with Genom allows us to explore the microbiome in regions that have been largely overlooked,” said Oliver Worsley, CEO of Sequential Skin Ltd . “It’s an exciting step toward building a richer, more representative microbiome dataset — one that will ultimately lead to better, more inclusive solutions in personal care and health.” “We are proud to be bringing world-class microbiome testing to our local industry. This partnership allows brands in our region to validate their innovations scientifically and competitively,” said Maja Barbalić, CEO of Genom d.o.o . About Genom d.o.o. Genom is a Croatian-based company specializing in molecular diagnostics and human genetics. Leveraging a scientific foundation and strategic industry connections, Genom supports its partners in bringing evidence-based innovations to market. About Sequential Skin Ltd Sequential is the world’s leading microbiome platform for skin, scalp and intimate area clinical microbiome testing. Sequential has collected over 25,000 microbiome samples, using machine learning to combine microbiome + clinical data + formulations, for effective personal care and healthcare applications. They are backed by Innovate UK Smart Grants, Enterprise Singapore, Corundum Systems Biology, SOSV, Scrum Ventures, and Metaplanet Holdings. Clients include Johnson & Johnson, Walgreens Boots Alliance, and 60 other leading clients in personal care and pharmaceutical.

  • Clinical Study Recruitment | Sequential

    The right participants for your clinical study. We recruit and screen cohorts by phenotype, behaviour and health status, not demographics alone. The Right Participants for Your Research Recruit study populations matched to your protocol, product and research objectives. From healthy participants and targeted consumer profiles to specific skin, scalp, oral and intimate health characteristics, Sequential builds human cohorts around the questions you need to answer. Discuss your recruitment needs Recruitment Built for Human Research 10,000 Participants in our network 100+ Recruited studies 6mos. + Age range 3 Recruitment labs Who can you recruit Find the Population Your Study Needs Go beyond broad demographics. Sequential recruits and screens participants against study-specific inclusion and exclusion criteria, helping you build cohorts defined by phenotype, condition, behaviour, demographics and other relevant characteristics. Targeted Populations Study-specific characteristics and defined populations aligned with your protocol and research objectives. Go Beyond Demographics The right study population isn't defined by age and sex alone. Sequential can combine demographic, phenotypic, behavioural and health characteristics to identify participants aligned with your biological and clinical research questions. How recruitment works From Protocol to Participant We translate your study objectives into practical recruitment criteria, identify suitable participants and manage screening through enrolment, helping build the right cohort before your study begins. 01 Define Translate your protocol and research objectives into participant criteria. 02 Identify Match potential participants against demographic, phenotypic, behavioural and health characteristics. 03 Screen Pre-screen against study-specific inclusion and exclusion criteria. 04 Enrol Confirm eligible participants and coordinate enrollment into your study. 05 Retain Support participants throughout the study to help maintain engagement and protocol compliance. Personal care and pharma Recruitment Across Consumer & Therapeutic Research Recruitment Across Consumer & Therapeutic Research Recruit targeted consumer populations for skincare, scalp care, oral care, intimate care and supplement studies, from product efficacy and claims research to exploratory biomarker studies. Pharma & Therapeutics Recruit study populations around defined clinical and biological characteristics for dermatology and other therapeutic research, aligned with protocol-specific eligibility criteria. SKIN SCALP ORAL INTIMATE SUPPLEMENTS Next steps Planning a study or want to join one? For Brands and Researchers For Participants Run a study with us Take part in research Send us your eligibility criteria and we will come back on feasibility, timelines and cost. See what studies we're recruiting for now or register your interest and we'll be in touch. Design Your Study Join a Study Check out our ongoing studies Ongoing studies Supporting Global Studies Our Labs Sequential has clinical testing labs in New York City, Cambridge, and Singapore. Being close to our customers has allowed us to reduce turnaround time while retaining intellectual property in-house. Cambridge Lab Moneta Building Babraham Research Campus, Cambridge CB22 3AT New York Lab Sequential (SOSV) 7 Penn Plaza, 9th Fl, New York NY 10001 Singapore Lab Astar Central 79 Ayer Rajah Crescent, Singapore 139955

  • Ongoing Clinical Studies | Sequential

    See what's currently underway at Sequential. Active human clinical studies across skin, scalp, oral care and skin health supplements. Ongoing Studies US Lab Studies UK Lab Studies Singapore Lab Studies US Lab Studies Status: In Progress Topical Moisturiser Study (Sensitive Skin) Randomised, evaluator-blinded, exploratory trial comparing a moisturiser vs. occlusive control on contralateral volar forearms; TEWL, corneometry, pH, questionnaire and microbiome/inflammatory panel at screening, baseline and day 28. Number of Participants: 24 targeted for recruitment Recruitment Criteria: Adults 18–55, self-declared sensitive skin, mixed Fitzpatrick types, screening TEWL >15 g/m²/h, 7-day product washout required Status: In Progress Vaginal Microbiome Study (Intimate Wipe) Studies an intimate wipe product's effect on vulvar/vaginal microbiome and pH; swabs at baseline (cycle day 5–7) and day 30. Number of Participants: 35 recruited; 30 samples analysed Recruitment Criteria: Healthy participants Status: In Progress Acne Microbiome Study (Topical Antibacterial) Active-vs-placebo study of a topical antibacterial product; patch collection at day 0 and week 12 (may shift to day 28). Number of Participants: 30 analysed (15 product / 15 placebo) Recruitment Criteria: Participants with acne lesions Status: In Progress Oral Probiotic Study (Multiple Indications) Double-Blinded, Placebo-Controlled, Longitudinal Study. Skin (Facial); Oral supplement impact on skin health and cosmetic improvements; Blood and patch/swab samples taken for omics and biomarker assessments. Number of Participants: 140 Recruitment Criteria: Multi-centre meta-analysis Status: In Progress Intimate Care Product Microbiome Meta-Analysis Secondary meta-analysis of existing microbiome data from prior intimate-care product studies, rather than a new primary study with its own recruited cohort. Number or Participants: 300+ Recruitment Criteria: Multi-centre meta-analysis Status: In Progress Vulvar Odor Product Study (Gel Wash & Wipes) Randomized, open-label, crossover study of an odor-control gel wash and wipes on the vulvar area; swabs at baseline, week 1 and week 2 for each product, assessing malodor, pH and targeted metabolomics. Number or Participants: 45 recruited; target 40 completers Recruitment Criteria: Healthy participants Status: In Progress Hair & Scalp Microbiome Study (Oral Supplement) Longitudinal, open-label, single-arm multi-omics study evaluating a daily oral hair/scalp supplement's effect on scalp microbiome and gene expression; scalp samples collected at baseline, week 4 and week 8. Number or Participants: 65 (15-participant subset for gene expression analysis) Recruitment Criteria: Healthy participant Status: In Progress Body Wash Skin Study (Onsite) Randomised controlled trial of a body wash on volar forearm skin; microbiome (patch) and biophysical measures (pH, TEWL, Corneometer) over 7 days; lipidomic samples collected but stored for future analysis only. Number of Participants: 35 (15 active / 15 vehicle control) Recruitment Criteria: Mixed men and women, aged 18–65, normal skin type, at least one participant per Fitzpatrick type I–VI Status: In Progress Topical Active Ingredient Study (Eczema-Prone Skin) Single-site, randomised, double-blind, placebo-controlled study of a topical active ingredient (two concentrations) on eczema-affected skin; swabs and biophysical metadata at baseline and week 2. Number of Participants: 36 (two active concentrations plus placebo) Recruitment Criteria: Female and/or male, aged 18–75, mild-to-moderate eczema (excluding feet and face), all races/ethnicities Status: In Progress Acne Skincare Regimen Study (On-site) On-site clinical study of a multi-step skincare regimen (cleanser, moisturizer, exfoliant); dermatologist grading, imaging, microbiome swabs and biophysical measures at day 0, 14 and 30. Number of Participants: 25 Recruitment Criteria: Moderate acne (5+ active lesions), male and female, ethnically diverse Status: In Progress Vulvar & Vaginal Malodor Study (Menstrual Care Product) Randomised controlled trial of a menstrual care product (active vs placebo); vulvar and vaginal microbiome/metabolites assessed via 16S sequencing at baseline, day 7 and day 14. Number of Participants: 40 Recruitment Criteria: Females aged 18+ Status: In Progress Facial Moisturiser Study Single-arm clinical trial of a facial moisturiser; skin patch samples collected at baseline, week 1 and week 4. Number or Participants: 35 Recruitment Criteria: Healthy participants with oily/combination facial skin Status: In Progress Axillary Malodor Study (Deodorant) Assesses a deodorant product's effect on the axillary (underarm) microbiome linked to malodor; underarm swabs at baseline and 48 hours post-application, analyzed with a targeted qPCR malodor panel. Number or Participants: 44 Recruitment Criteria: Healthy participants undergoing deodorant efficacy testing UK Lab Studies Status: In Progress Post-Procedure Skin Microbiome Study (Scar Sites) Longitudinal, placebo-controlled study of skin microbiome changes at recent minor-procedure (mole-removal) sites; swabs at Day 0 and Day 28. Number of Participants: 50 recruited; 30 selected for sequencing analysis (15 product / 15 placebo) Recruitment Criteria: Subjects who have recently undergone a minor skin procedure (mole removal) Status: In Progress Oral Probiotic & Skin Health Clinical Trial Double-blinded, placebo-controlled, longitudinal in-person trial of an oral probiotic's effect on facial skin health (wrinkles, TEWL, elasticity, moisture) via imaging, biophysical measures and omics sampling over 12 weeks. Number of Participants: 128 completers targeted; 140 recruited (2 arms, 64 per arm) Recruitment Criteria: Healthy women, dry to very dry skin, aged 35–45 Status: In Progress Recurrent UTI Probiotic Clinical Trial Remote randomised controlled trial (blinded, placebo- and active-controlled) of a probiotic for recurrent UTI prevention; vaginal, urine and stool sampling at baseline, 3 and 12 months (plus urine at each UTI episode). Number of Participants: 100 target completers (110 enrolled, allowing for dropout) Recruitment Criteria: History of recurrent UTIs (3+ in 12 months), diagnosed by a doctor and prescribed antibiotics Status: In Progress Axillary (Underarm) Skin Study (Split-Body Design) Placebo-controlled, split-body (split-armpit) study of microbiome/metabolite changes after product use; untargeted metabolomics and qPCR skin panel. Number of Participants: 30 recruited; analysis performed on 25 participants Recruitment Criteria: Healthy volunteers; recruited externally by the study sponsor Singapore Lab Studies Status: In Progress Facial Skin Metatranscriptomics Study (Exploratory) Controlled, within-subject crossover pilot study of product-driven change in facial skin microbiome function via metatranscriptomics across two products. Number of Participants: 12 adults Recruitment Criteria: Healthy adults pre-selected for high bacterial load per sponsor's pre-screening criteria Status: In Progress Eczema Cream Microbiome Study (Metatranscriptomics) Randomised, double-blind, placebo-controlled, longitudinal study of an eczema cream; skin microbiome swabs (metatranscriptomics) from the forearm (and possibly other areas) at baseline and day 28. Number of Participants: 20 (10 active / 10 vehicle control) Recruitment Criteria: Atopic dermatitis/eczema-prone skin, mild-to-moderate severity; sampling limited to the treated lesion area What do I do next? Planning a clinical study? Tell us about your product and what you're looking to prove. We'll help you identify the right study design and measurements. Design Your Study

  • How It Works | Sequential

    Full End-To-End Testing Platform From study design and participant recruitment to laboratory analysis and data interpretation, Sequential delivers an end-to-end, in-house solution for understanding how products interact in real use cases. Our clinically relevant insights translate complex microbial and molecular data into clear, actionable outcomes empowering companies to develop products that are credible, effective, and trusted by consumers. Consultation & Study Design We collaborate with each client to create customised study protocols that align with specific objectives and ensure scientific precision. Clinically Validated Collection Our non-invasive collection system delivers consistent, high-quality samples and enables remote testing when needed. In-house Analysis & Reporting All analysis is performed in-house, ensuring speed, consistency, and direct access to our scientific and formulation experts. Candidate Recruitment Human participants are carefully selected by age, location, and other criteria to ensure relevant, accurate results. Multi-Omics Detection We combine microbiome sequencing, multi-omics technologies, and biophysical assessments to deliver a complete picture of skin health and product impact. Clinically Backed Results Our scientifically grounded reports transform complex data into claim-ready insights, empowering confident communication.

  • Non-Invasive Sample Collection | Sequential

    Non-invasive sampling designed around real product use. Validated methods that collect human and microbial samples remotely or in the clinic. Complete, high-quality human samples in just 10 seconds In Vivo Testing For Skincare Formulations Our collection system is engineered for simplicity and consistency, enabling participants to self-collect complete skin samples in seconds with minimal training. Designed to perform reliably across both clinical and consumer settings, it supports scalable study designs while maintaining high data integrity from every sample. Improve your sample quality Up to 3× more biomass than traditional swabs Higher-resolution data, without added complexity. How do you stand out Designed for high-quality, real-world sample collection Up to 3× more biomass than swabs for microbiome analysis 10-second, non-invasive collection suitable for remote and in-clinic use Room temperature stability for simple logistics and global shipping Externally validated across multiple clinical studies Tested across 7 body sites for broad dermatological application DNA Yield By Method Consistently outperforms the swabbing and tape strip method for skin sampling. Validated Sampling Sites P1 D1 P2 D2 P3 D3 P4 D4 P5 D5 P6 D6 P7 D7 Clinically tested on 7 unique body sites. The Sequential Patch Flexible collection, designed for any study model The Sequential Patch is designed to support both decentralized and in-clinic study designs, adapting to the needs of each project without compromising data quality. Whether integrated into fully remote studies, CRO-led trials, or conducted within our own facilities, our collection system ensures consistent, high-quality sampling across all environments. What do I do next? Planning a study? Tell us about your product and what you're looking to prove. We'll help you identify the right study design and measurements. Design Your Study

bottom of page